Overview

COVID-19 (VA CURES-1)

Status:
Completed

Trial end date:
2021-09-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if treatment with convalescent plasma improves the clinical outcomes of Veterans who are hospitalized and require supplemental oxygen due to COVID-19.

Phase:

Phase 3

Details

Lead Sponsor:

VA Office of Research and Development